Table 1.
Participant and visit characteristics (N=175)
| Characteristic | Number of patients (%) |
|---|---|
| Mean Age, years (SD) | 55.4 (10.7) |
| Age <50 | 55 (31%) |
| Age ≥50 | 120 (69%) |
| Menopausal* | |
| No | 14 (8%) |
| Yes | 155 (92%) |
| Race | |
| White | 155 (89%) |
| Black | 11 (6%) |
| Asian | 6 (3%) |
| Other/Refused | 3 (2%) |
| Marital Status | |
| Single | 46 (26%) |
| Married /Partnered | 107 (61%) |
| Divorced/Separated/Widowed | 22 (13%) |
| Type of Cancer* ^ | |
| Breast | 90 (53%) |
| Gynecologic | 54 (32%) |
| Colorectal/Anal | 15 (9%) |
| Gastric/Genitourinary | 6 (4%) |
| Skin | 5 (3%) |
| Hematologic | 3 (2%) |
| Other (Sarcoma, Head/Neck, Liver, Lung, High-risk BRCA, non-cancerous conditions) |
12 (7%) |
| Actively on Treatment* | 83 (49%) |
| Endocrine therapy (AI, Tamoxifen) | 62/83 (75%) |
| Chemo/biological therapy | 10/83 (12%) |
| Hormonal (e.g., estradiol vaginal tablets) | 17/83 (20%) |
| Radiation therapy | 3/83 (4%) |
| Prior Radiation Therapy*# | 97 (57%) |
| Upper radiation therapy (i.e., chest) | 61/97 (63%) |
| Lower radiation therapy (i.e., pelvic, abdominal) |
36/97 (37%) |
| Palliative radiation therapy | 1/97 (1%) |
| Total Number of Visits at Time of Analysis | |
| 2 | 51 (29%) |
| 3 | 37 (21%) |
| 4 | 33 (19%) |
| 5 | 15 (9%) |
| 6+ | 39 (22%) |
|
Median time from first to last visit, months (IQR) |
4.1 (2.3, 6.0) |
AI, aromatase inhibitor
*
Data missing for 6 patients.
^
Percentages may not add up to 100 as patients can have more than one diagnosis/response.
#
One patient received both upper and lower radiation therapy